LIFECORE BIOMEDICAL, INC. (LFCR)

Every figure this model derived for LFCR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-05-25.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 13,415,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-05-25
cash 18,538,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 83,691,000 AssetsCurrent 2026-06-30
current liabilities 21,641,000 LiabilitiesCurrent 2026-06-30
equity -34,094,000 StockholdersEquity 2026-06-30
interest expense 22,168,000 InterestExpenseDebt 2025-05-25
ocf -206,000 NetCashProvidedByUsedInOperatingActivities 2025-05-25
revenue 128,867,000 RevenueFromContractWithCustomerIncludingAssessedTax 2025-05-25
sbc 10,158,000 ShareBasedCompensation 2025-05-25

The ratios

The figures themselves rather than their scores — what somebody looking up LFCR on one particular measure came for.

RatioValue
cash operating margin0.72
current ratio3.87
current ratio reported3.87
deferred revenue growth1.62
dilution pct-5.03
fcf margin-10.57
interest cover-0.78
operating margin-13.38
owner earnings margin-18.45
revenue growth0.47
revenue growth per share5.8
roic-12.48
rule of 40-12.91
sbc pct revenue7.88

What to be careful about

What this model itself distrusts about LFCR's figures. Written by the derivation as it ran, not added afterwards.